New Jersey A 954: Provides that purchase of insulin is not subject to deductible; requires health insurers to limit copayments and coinsurance for insulin; requires insulin manufacturers to submit report to Commissioner of Banking and Insurance.***

Status: Reported out of Assembly Committee with Amendments, 2nd Reading (as of 2021-06-16)

State: New Jersey · Session: 219 · Bill: A 954

Subjects: CONSUMER PRO, DISEASE, HEALTH INSUR, PHARMACEUTIC

Sponsors: Armato, John, Karabinchak, Robert J., Quijano, Annette, Benson, Daniel R., DeAngelo, Wayne P., Downey, Joann, Freiman, Roy, Giblin, Thomas P., Jasey, Mila M., Lampitt, Pamela R., Mazzeo, Vincent, Reynolds-Jackson, Verlina, Stanley, Sterley S., Timberlake, Britnee N., Vainieri Huttle, Valerie

View New Jersey A 954 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.